Cullinan Associates’s Intuitive Surgical ISRG Stock Holding History

Cullinan Associates’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.26M	Hold	4,900	–	–	0.18%	87
2025 Q4	$2.78M	Hold	4,900	–	–	0.19%	91
2025 Q3	$2.19M	Hold	4,900	–	–	0.14%	101
2025 Q2	$2.66M	Hold	4,900	–	–	0.18%	98
2025 Q1	$2.43M	Hold	4,900	–	–	0.17%	99
2024 Q4	$2.56M	Hold	4,900	–	–	0.16%	100
2024 Q3	$2.54M	Sell	4,900 -1,500	-23%	-$698K	0.14%	108
2024 Q2	$2.85M	Hold	6,400	–	–	0.16%	96
2024 Q1	$2.55M	Buy	6,400 +4,800	+300%	+$1.81M	0.14%	109
2023 Q4	$540K	Hold	1,600	–	–	0.03%	179
2023 Q3	$468K	Hold	1,600	–	–	0.03%	193
2023 Q2	$547K	Buy	1,600 +100	+7%	+$30.3K	0.03%	188
2023 Q1	$383K	Hold	1,500	–	–	0.02%	203
2022 Q4	$398K	Hold	1,500	–	–	0.02%	220
2022 Q3	$281K	Hold	1,500	–	–	0.02%	208
2022 Q2	$301K	Hold	1,500	–	–	0.02%	199
2022 Q1	$453K	Hold	1,500	–	–	0.02%	182
2021 Q4	$539K	Hold	1,500	–	–	0.03%	178
2021 Q3	$497K	Hold	1,500	–	–	0.03%	180
2021 Q2	$460K	Hold	1,500	–	–	0.03%	177
2021 Q1	$369K	Buy	+1,500	New	+$377K	0.02%	175

Other funds holding ISRG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cullinan Associates's ISRG Position: Q1 2026 in Review

Cullinan Associates held its Intuitive Surgical (ISRG) position steady in Q1 2026 at 4,900 shares worth $2.26M. The position accounts for 0.18% of the portfolio, ranked #87.

Cullinan Associates first reported a position in ISRG in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.85M in Q2 2024. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

Cullinan Associates held 4,900 shares of Intuitive Surgical worth $2.26M as of Q1 2026.
Cullinan Associates left its Intuitive Surgical share count unchanged in Q1 2026.
Intuitive Surgical made up 0.18% of Cullinan Associates's portfolio in Q1 2026, its #87 holding.
Cullinan Associates first reported a position in Intuitive Surgical in Q1 2021 and has held it in 21 quarters since.
Cullinan Associates's Intuitive Surgical position peaked at $2.85M in Q2 2024.
2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.